Related Experiment Video
Updated: Jul 4, 2025

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Enhancing Gene Therapy through Ultradeformable Vesicles for Efficient siRNA Delivery.
Chintan Aundhia1, Nirmal Shah1, Chitrali Talele1
1Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Piparia, Waghodia, Vadodara, 391760, Gujarat, India.
Ultra-deformable vesicles enhance gene therapy by improving siRNA delivery past the skin's barrier. Optimized lipid formulations are key for effective siRNA encapsulation and targeted delivery in skin treatments.
Area of Science:
- Biotechnology
- Dermatology
- Gene Therapy
Background:
- The stratum corneum presents a significant barrier to topical delivery of molecules like small interfering RNA (siRNA).
- Gene therapy, involving the manipulation of gene expression, holds promise for treating various diseases.
- Ultra-deformable vesicles are being explored as advanced delivery systems for therapeutic agents.
Purpose of the Study:
- To investigate the role of ultra-deformable vesicles in overcoming the stratum corneum barrier for effective siRNA delivery.
- To optimize the composition and formulation of these vesicles for enhanced siRNA encapsulation and skin penetration.
Main Methods:
- Formulation and characterization of ultra-deformable vesicles with specific lipid compositions.
- Engineering vesicle properties to enhance deformability and stability.
- Assessment of siRNA encapsulation efficiency within the vesicles.
- Evaluation of vesicle penetration through the stratum corneum model.
Main Results:
- Optimized lipid selection and vesicle engineering resulted in uniform vesicles with enhanced deformability.
- Improved siRNA encapsulation efficiency was achieved through careful formulation.
- The ultra-deformable vesicles demonstrated potential to overcome the stratum corneum barrier for siRNA delivery.
Conclusions:
- Ultra-deformable vesicles represent a promising strategy for enhancing topical siRNA delivery in gene therapy applications.
- Further advancements in vesicle design and formulation are expected to improve therapeutic outcomes.
- Combination strategies and regulatory considerations are crucial for clinical translation.
More Related Videos
08:53Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013